WG Biotech ApS: Financial statements 2018
CVR: 36940131
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK 657,459,000 compared with DKK -220,191 the year before. Equity in the 2018 report amounted to DKK 657,034,000. The solvency ratio was 98.9%.
- Profit/Loss
- DKK 657,459,000
- Equity
- DKK 657,034,000
- Total Assets
- DKK 664,357,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | 657.5 mio. | 657 mio. | - |
| 2017 | - | - | -220 t. | -425 t. | - |
| 2016 | - | - | -265 t. | -204 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
WG Biotech ApS has published its annual report for 2017. The net result was DKK -220,191.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.